These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22700010)

  • 41. Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure.
    Gligorijević N; Aranđelović S; Filipović L; Jakovljević K; Janković R; Grgurić-Šipka S; Ivanović I; Radulović S; Tešić ZLj
    J Inorg Biochem; 2012 Mar; 108():53-61. PubMed ID: 22266461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Square-planar Pd(II), Pt(II), and Au(III) terpyridine complexes: their syntheses, physical properties, supramolecular constructs, and biomedical activities.
    Eryazici I; Moorefield CN; Newkome GR
    Chem Rev; 2008 Jun; 108(6):1834-95. PubMed ID: 18543874
    [No Abstract]   [Full Text] [Related]  

  • 43. Subcellular localization and transport kinetics of ruthenium organometallic anticancer compounds in living cells: a dose-dependent role for amino acid and iron transporters.
    Klajner M; Licona C; Fetzer L; Hebraud P; Mellitzer G; Pfeffer M; Harlepp S; Gaiddon C
    Inorg Chem; 2014 May; 53(10):5150-8. PubMed ID: 24786362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates.
    Bergamo A; Gaiddon C; Schellens JH; Beijnen JH; Sava G
    J Inorg Biochem; 2012 Jan; 106(1):90-9. PubMed ID: 22112845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
    Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
    Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective cytotoxic Ru(II) arene Cp* complex salts [R-PhRuCp*](+)X(-) for X = BF4(-), PF6(-), and BPh4(-).
    Loughrey BT; Healy PC; Parsons PG; Williams ML
    Inorg Chem; 2008 Oct; 47(19):8589-91. PubMed ID: 18783214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer cell cytotoxicity of cyclometalated compounds obtained with osmium(II) complexes.
    Boff B; Gaiddon C; Pfeffer M
    Inorg Chem; 2013 Mar; 52(5):2705-15. PubMed ID: 23427955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hexanuclear self-assembled arene-ruthenium nano-prismatic cages: potential anticancer agents.
    Vajpayee V; Yang YJ; Kang SC; Kim H; Kim IS; Wang M; Stang PJ; Chi KW
    Chem Commun (Camb); 2011 May; 47(18):5184-6. PubMed ID: 21451846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New ruthenium(II) complexes functionalized with coumarin derivatives: synthesis, energy-transfer-based sensing of esterase, cytotoxicity, and imaging studies.
    Li MJ; Wong KM; Yi C; Yam VW
    Chemistry; 2012 Jul; 18(28):8724-30. PubMed ID: 22693144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carbonyl-substituted titanocenes: a novel class of cytostatic compounds with high antitumor and antileukemic activity.
    Gansäuer A; Winkler I; Worgull D; Lauterbach T; Franke D; Selig A; Wagner L; Prokop A
    Chemistry; 2008; 14(14):4160-3. PubMed ID: 18384037
    [No Abstract]   [Full Text] [Related]  

  • 51. Ruthenium dendrimers against acute promyelocytic leukemia: 
    Michlewska S; Ionov M; Maroto-Díaz M; Szwed A; Ihnatsyeu-Kachan A; Abashkin V; Dzmitruk V; Rogalska A; Denel M; Gapinska M; Shcharbin D; Gomez Ramirez R; de la Mata FJ; Bryszewska M
    Future Med Chem; 2019 Jul; 11(14):1741-1756. PubMed ID: 31287722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
    Scolaro C; Bergamo A; Brescacin L; Delfino R; Cocchietto M; Laurenczy G; Geldbach TJ; Sava G; Dyson PJ
    J Med Chem; 2005 Jun; 48(12):4161-71. PubMed ID: 15943488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.
    Peacock AF; Sadler PJ
    Chem Asian J; 2008 Nov; 3(11):1890-9. PubMed ID: 18712745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Organometallic ruthenium and osmium compounds of pyridin-2- and -4-ones as potential anticancer agents.
    Henke H; Kandioller W; Hanif M; Keppler BK; Hartinger CG
    Chem Biodivers; 2012 Sep; 9(9):1718-27. PubMed ID: 22976964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
    Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
    J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ruthenium (II) nitrofurylsemicarbazone complexes: new DNA binding agents.
    Cabrera E; Cerecetto H; González M; Gambino D; Noblia P; Otero L; Parajón-Costa B; Anzellotti A; Sánchez-Delgado R; Azqueta A; López de Ceráin A; Monge A
    Eur J Med Chem; 2004 Apr; 39(4):377-82. PubMed ID: 15072846
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel ruthenium azo-quinoline complexes with enhanced photonuclease activity in human cancer cells.
    Kaulage MH; Maji B; Pasadi S; Bhattacharya S; Muniyappa K
    Eur J Med Chem; 2017 Oct; 139():1016-1029. PubMed ID: 28910739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA structural distortions induced by ruthenium-arene anticancer compounds.
    Gossens C; Tavernelli I; Rothlisberger U
    J Am Chem Soc; 2008 Aug; 130(33):10921-8. PubMed ID: 18651736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: passing the nanomolar barrier.
    Fetzer L; Boff B; Ali M; Xiangjun M; Collin JP; Sirlin C; Gaiddon C; Pfeffer M
    Dalton Trans; 2011 Sep; 40(35):8869-78. PubMed ID: 21837342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, spectroscopic characterization, photochemical and photophysical properties and biological activities of ruthenium complexes with mono- and bi-dentate histamine ligand.
    Cardoso CR; de Aguiar I; Camilo MR; Lima MV; Ito AS; Baptista MS; Pavani C; Venâncio T; Carlos RM
    Dalton Trans; 2012 Jun; 41(22):6726-34. PubMed ID: 22539182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.